News & Articles

The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test

The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases

Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases

Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19

Gallant ICD and CRT-D devices feature a patient-preferred design without compromising on battery longevity and compatibility with magnetic resonance imaging (MRI)

Prof. Ishii explains how high-sensitivity troponin I assays and a 1-hour algorithm can be best used for early diagnosis and treatment of myocardial infarction

binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

Investment in state-of-the-art automation cements Abingdon Health’s position as a leading global rapid test manufacturer

Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs

Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology

The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.